PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection.

Abstract Intraamniotic infection, also known as chorioamnionitis, is an infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua. Intraamniotic infection is a common condition noted among preterm and term parturients. However, most cases of intraamniotic infection detected and managed by obstetrician-gynecologists or other obstetric care providers will be noted among term patients in labor. Intraamniotic infection can be associated with acute neonatal morbidity, including neonatal pneumonia, meningitis, sepsis, and death. Maternal morbidity from intraamniotic infection also can be significant, and may include dysfunctional labor requiring increased intervention, postpartum uterine atony with hemorrhage, endometritis, peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death. Recognition of intrapartum intraamniotic infection and implementation of treatment recommendations are essential steps that effectively can minimize morbidity and mortality for women and newborns. Timely maternal management together with notification of the neonatal health care providers will facilitate appropriate evaluation and empiric antibiotic treatment when indicated. Intraamniotic infection alone is rarely, if ever, an indication for cesarean delivery.
PMID
Related Publications

Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation.

Antibiotic regimens for management of intraamniotic infection.

Intrapartum antibiotic therapy for suspected intraamniotic infection: impact on the fetus and neonate.

Antibiotic regimens for management of intra-amniotic infection.

Committee Opinion No. 712 Summary: Intrapartum Management of Intraamniotic Infection.

Authors

Mayor MeshTerms
Keywords
Journal Title obstetrics and gynecology
Publication Year Start




PMID- 28742677
OWN - NLM
STAT- MEDLINE
DA  - 20170725
DCOM- 20170809
LR  - 20170809
IS  - 1873-233X (Electronic)
IS  - 0029-7844 (Linking)
VI  - 130
IP  - 2
DP  - 2017 Aug
TI  - Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection.
PG  - e95-e101
LID - 10.1097/AOG.0000000000002236 [doi]
AB  - Intraamniotic infection, also known as chorioamnionitis, is an infection with
      resultant inflammation of any combination of the amniotic fluid, placenta, fetus,
      fetal membranes, or decidua. Intraamniotic infection is a common condition noted 
      among preterm and term parturients. However, most cases of intraamniotic
      infection detected and managed by obstetrician-gynecologists or other obstetric
      care providers will be noted among term patients in labor. Intraamniotic
      infection can be associated with acute neonatal morbidity, including neonatal
      pneumonia, meningitis, sepsis, and death. Maternal morbidity from intraamniotic
      infection also can be significant, and may include dysfunctional labor requiring 
      increased intervention, postpartum uterine atony with hemorrhage, endometritis,
      peritonitis, sepsis, adult respiratory distress syndrome and, rarely, death.
      Recognition of intrapartum intraamniotic infection and implementation of
      treatment recommendations are essential steps that effectively can minimize
      morbidity and mortality for women and newborns. Timely maternal management
      together with notification of the neonatal health care providers will facilitate 
      appropriate evaluation and empiric antibiotic treatment when indicated.
      Intraamniotic infection alone is rarely, if ever, an indication for cesarean
      delivery.
CN  - Committee on Obstetric Practice
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PL  - United States
TA  - Obstet Gynecol
JT  - Obstetrics and gynecology
JID - 0401101
RN  - 0 (Anti-Bacterial Agents)
SB  - AIM
SB  - IM
MH  - Anti-Bacterial Agents/*therapeutic use
MH  - Chorioamnionitis/*drug therapy
MH  - Female
MH  - Humans
MH  - Obstetrics/*standards
MH  - Pregnancy
MH  - Prenatal Care/*standards
IR  - Heine RP
FIR - Heine, R Phillips
IR  - Puopolo KM
FIR - Puopolo, Karen M
IR  - Beigi R
FIR - Beigi, Richard
IR  - Silverman NS
FIR - Silverman, Neil S
IR  - El-Sayed YY
FIR - El-Sayed, Yasser Y
EDAT- 2017/07/26 06:00
MHDA- 2017/08/10 06:00
CRDT- 2017/07/26 06:00
AID - 10.1097/AOG.0000000000002236 [doi]
AID - 00006250-201708000-00057 [pii]
PST - ppublish
SO  - Obstet Gynecol. 2017 Aug;130(2):e95-e101. doi: 10.1097/AOG.0000000000002236.